The short answer
PI-RADS 3 means the MRI is equivocal for clinically significant prostate cancer. PI-RADS v2.1 deliberately gives no biopsy rule for a 3, so PSA density and prior biopsy history carry the decision.
PI-RADS v2.1 says biopsy should be considered for 4 or 5 and not for 1 or 2; for a 3 it declines to say, on purpose.
Across 28 studies, clinically significant cancer was found in about 18.5% of PI-RADS 3 cases, so most are not significant cancer.
PSA density, calculated from PSA and prostate volume, is the number urologists most often use to break the tie.
Choose how you want to understand this
The full explanation.
Equivocal is the actual word
PI-RADS v2.1 defines category 3 as intermediate, and spells out what that means: the presence of clinically significant cancer is equivocal.
Not low. Not high. The scan looked, and it could not say.
That is an honest reading of a real image, not a hedge or a delay. Some prostates simply do not show a clear answer on MRI.
The system refuses to tell you what to do next
This is the part that surprises people, and it is deliberate.
PI-RADS v2.1 says biopsy should be considered for a 4 or a 5, and not for a 1 or a 2. For a 3 it stops. The document states that for findings with assessment category 3, biopsy may or may not be appropriate, depending on factors other than the MRI alone.
It also says PI-RADS does not include management recommendations at all, because those depend on lab results, clinical history, local expertise, and standards of care.
So a PI-RADS 3 report is not an incomplete report. The gap is where the conversation goes.
The scan is not allowed to know your PSA
PI-RADS v2.1 instructs that the category be based on MRI findings only. It should not take in your PSA, your rectal exam, your history, or any planned treatment.
That keeps the score clean, but it also means the score arrives missing exactly the information that decides the next step. Your urologist puts it back.
What a 3 turns out to be
A review pooled 28 studies covering 1,759 PI-RADS 3 cases. PI-RADS 3 made up about 17.3% of the scans, though that ranged widely between centers.
When those equivocal lesions were biopsied:
- prostate cancer of any kind was found in about 36%
- clinically significant cancer was found in about 18.5%
A separate meta-analysis of 56 studies and 16,537 men, using PI-RADS version 2, put the positive predictive value for significant cancer at PI-RADS 3 at 13%.
The two figures differ because the studies define significance differently and biopsy differently. Both point the same way. Most PI-RADS 3 findings are not significant cancer, and a meaningful minority are.
PSA density is the number that usually decides
PI-RADS v2.1 says prostate volume should always be reported, and notes it can be used to calculate PSA density: PSA divided by prostate volume.
The reason it helps is simple. A big prostate makes more PSA without any cancer. Dividing by size strips out that effect.
The review of PI-RADS 3 cases concluded that a PSA density of 0.15 ng/mL per mL or above may serve as an index for deciding whether to biopsy an equivocal lesion, and that a value below that may select men for follow-up instead.
That is a threshold used to weigh a choice. It is not a diagnosis, and your team may use a different cut-off.
Why the same lesion can score 3 or 4
Knowing how a 3 is built explains how close some of them sit to a 4.
In the peripheral zone, the outer part of the gland, the diffusion images lead. A lesion scored 3 on diffusion moves up to PI-RADS 4 if the contrast series is positive.
In the transition zone, the inner part, the T2 images lead. A T2 score of 3 becomes PI-RADS 4 when the diffusion score reaches 5.
So "3" can mean a finding that nearly qualified, or one that barely registered. The written description in the report tells you which.
Reasonable paths from here
Both watching and sampling are defensible after a 3. What matters is that the choice is made with the rest of your picture:
- repeat PSA and recalculate density
- a targeted biopsy of the lesion, with or without systematic cores
- a repeat MRI after an interval, to see whether anything changes
- a second read of the same images by another prostate MRI specialist
Ask what each option would rule in or out, and what happens if it is negative.
Questions for the urology visit
- What is my PSA density?
- Which zone was the lesion in, and how was it described?
- Was the image quality good enough to be confident?
- If we biopsy and it is negative, what then?
- If we wait, when is the next test and what would change the plan?
Related reading
Start with What Does PI-RADS Mean for the scale as a whole, and What Does PI-RADS 4 Mean for the next rung up. See also Elevated PSA: What Now and Prostate Cancer.
Sources
- American College of Radiology — PI-RADS
- ACR PI-RADS v2.1 document
- Maggi M et al. PI-RADS 3 Category Cases at Multiparametric MRI: Systematic Review and Meta-analysis. Eur Urol Focus. 2020
- Mazzone E et al. Positive Predictive Value of PI-RADS Version 2 for Detection of Clinically Significant Prostate Cancer. Eur Urol Oncol. 2021
Words to know
Tap any term to see what it means.
Common questions
Does PI-RADS 3 mean I probably have prostate cancer?
No. PI-RADS 3 means the scan is equivocal. In a meta-analysis of 28 studies covering 1,759 PI-RADS 3 cases, any prostate cancer was found in about 36% and clinically significant cancer in about 18.5%.
Why does the report not recommend a biopsy?
Because the system does not do that. PI-RADS v2.1 states that it does not include management recommendations, and that for a category 3 finding biopsy may or may not be appropriate depending on factors beyond the MRI.
What is PSA density?
It is your PSA divided by the volume of your prostate, which PI-RADS v2.1 says should always be reported. A large gland can raise PSA without cancer, so the ratio is more informative than PSA alone.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-21 what this meansLast updated: 2026-08-10Next planned review: 2027-07-21
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share